In this issue of Neuron, Zhang et al. (2018) report a powerful new method for probing subcellular microdomain-specific signaling in cellular function. Through a microdomain-targeting approach, they delineate how Ras-family GTPases balance signaling diversity with specificity required for various forms of hippocampal synaptic plasticity.
Cells seek out efficiency wherever they can find it; this is particularly evident in the design of signaling pathways within cells. One method for improving efficiency is to reuse signaling molecules across a broad range of cascades, expanding the range of possible outputs. However, this strategy could result in the loss of signaling specificity as incoming signals converge on the same intermediary ''hub'' involved in multiple signaling pathways. In this issue of Neuron, Zhang et al. (2018) developed a targeted delivery method that permits specific expression of multiple forms of Ras-family small GTPases in different subcellular microdomains. Using this powerful approach, they have defined detailed mechanisms by which the highly homologous Rasfamily proteins regulate various forms of synaptic plasticity (Figure 1 ). In doing so, this study has significantly advanced our understanding of the long-standing cell biology question ''how does a cell ensure that its signaling molecules achieve both signal diversity and specificity? '' Synaptic plasticity is characterized as a capacity or an ability of a synapse to readily change its transmission efficacy in response to environmental demands and is considered the basis of information storage in the brain (Collingridge et al., 2004; Malenka and Nicoll, 1999) . The best-studied examples of synaptic plasticity are long-term potentiation (LTP; Figure 1A ) and long-term depression (LTD; Figure 1E ) at the glutamatergic synapses of the CA1 region of the hippocampus. In addition, LTD can also be induced following the establishment of LTP, in which case it is called depotentiation ( Figure 1C ) (Collingridge et al., 2010) . At the molecular level, LTP is expressed as increased postsynaptic AMPA receptors (AMPARs) due to a facilitation of GluA1-dependent AMPAR insertion, whereas the expression of both LTD and depotentiation are mediated by decreased postsynaptic AMPARs due to the facilitation of GluA2-dependent AMPAR endocytosis (Collingridge et al., 2004; Malenka and Nicoll, 1999) . The physiological and pathological significance of these forms of synaptic plasticity makes the detailed characterization of their underlying mechanisms and potential crosstalk a matter of great importance.
Ras-family GTPases-including Ras, Rap1, and Rap2-are membrane-associated, small G proteins that are activated in response to diverse extracellular signals and, in turn, initiate a broad variety of downstream signaling cascades (Ye and Carew, 2010) . Ras-family proteins are known to play key roles in governing synaptic transmission and plasticity. Ras is believed to act through various kinases, such as ERK and PI3K, to increase synaptic strength (LTP) (Ye and Carew, 2010) . Conversely, Rap1, which is structurally similar to Ras, has been shown to decrease synaptic strength (LTD) by engaging a different kinase, P38MAPK. Finally, Rap2 promotes the reversal of synapse strengthening (depotentiation) through activation of yet another kinase, JNK. This complex pattern of parallel signaling cascades stemming from structurally similar Ras family proteins generates a paradox of sorts: how, in the face of multiple forms of plasticity acting through similarly structured proteins, is signal specificity required for synaptic plasticity maintained? In the present study, Zhang et al. (2018) have addressed this daunting task by providing several lines of evidence suggesting a critical role for subcellular microdomain-specific compartmentalization in determining the functions of Ras-family signaling molecules/complexes in various forms of synaptic plasticity (Figure 1) .
To accomplish this, they developed a powerful subcellular microdomain-targeting strategy by engineering signaling sequences that target select subcellular microdomains, including the bulk membrane, endoplasmic reticulum (ER), Golgi apparatus, lipid rafts, and lysosome domains. Combination of these sequences with mutant versions of Ras-family proteins, including constitutively active (ca-), catalytically-dead (dd-), and dominantnegative (dn-) forms of Ras, Rap1, or Rap2, coupled with florescent reporters and powerful multiple patch-clamp recordings, allowed for unprecedented functional dissection of the roles of microdomain-selective Ras family proteins in synaptic transmission and plasticity. Then, by elegantly applying this approach, Zhang et al. (2018) provided several lines of evidence supporting a critical role of subcellular microdomain-specific localization of Ras proteins in determining how they contribute to different forms of synaptic plasticity (Figure 1 ).
Following confirmation of appropriate targeting, they virally expressed constructs . When targeted to the bulk membrane, Rap2 may reverse potentiation through (1) promoting receptor endocytosis, (2) preventing AMPA receptor cycling back to the plasma membrane, or (3) promoting lateral diffusion of receptors outside of the synapse. (E and F) Schematic showing the profile of LTD (E), which relies on activation of P38MAPK through lysosomal Rap1 (F). Selective targeting of Rap1 to the lysosome leads to: (1) increased lysosomal activity that degrades AMPARs targeted to the lysosome, (2) P38MAPK activation, which may inhibit GluA2-containing receptor cycling back to the synapse (red line), or (3) decreasing stability of synaptically localized AMPARs, thereby promoting their lateral diffusion out of the synapse.
containing the various mutant (ca, dd, dn; see above) forms of Ras proteins with the various microdomain-targeting sequences and performed simultaneous whole-cell recordings of CA1 neurons in slice cultures. Constitutively active Ras increased AMPAR currents when localized to the ER, with no effect of the dn-Ras, which disrupts endogenous Ras activity. Similarly, when ca-Ras was expressed in lipid rafts, it also increased AMPAR responses. However, expression of dn-Ras in lipid rafts also reduced basal AMPAR responses, suggesting that Ras maintains tonic levels of AMPAR responses exclusively through lipid rafts, representing a functional dissociation for Ras between these two domains. These findings demonstrate the power of this technique for deciphering bidirectional and microdomain-exclusive modulatory effects of signaling molecules. Zhang et al. (2018) next tested whether Rap1 and Rap2 demonstrate microdomain-restricted functional dissociations. They discovered that when Rap1 activity was chronically elevated (caRap1) in the lysosome, AMPAR responses were reduced, whereas simulating loss of Rap1 activity (dn-Rap1) increased AMPAR currents. Interestingly, AMPAR transmission was reduced only when Rap2 activity was elevated in bulk membranes. These results have implications for so called ''Rasopathies''(Bentires-Alj et al., 2006), as they suggest that signaling deficits associated with Ras-family proteins could go beyond canonical gain-or loss-of-function pathologies to mis-localization or microdomain expression imbalances. Zhang et al. (2018) then sought to determine whether microdomains serve as isolated signaling complexes. To probe this, they pharmacologically blocked the Ras pathways associated with potentiation, PI3K or ERK. PI3K was required for caRas-dependent AMPAR potentiation in the ER but not in lipid rafts, whereas ERK inactivation blocked potentiation in both domains. Further, the potentiation effects of ca-Ras in the ER were lost in AMPAR GluA1 subunit knockout neurons or GluA1 mutant neurons that lack phosphorylation modification sites required for LTP. Potentiation triggered by Ras activity in lipid rafts required AMPARs containing GluA2 subunits as demonstrated in GluA2 knockout neurons. Taken together, these results confirm that domain-selective expression of Ras results in the preferential recruitment of PI3K (ER) or ERK (lipid rafts) signaling cascades that regulate AMPAR function in a subunit-specific manner. They further found that Rap2 recruits JNK in the bulk membrane to depress AMPAR transmission, which was verified by dn expression of the JNK-specific substrate TNIK, whereas activated Rap1 in the lysosome drives synaptic depression through P38MAPK. Collectively, these results show yet another powerful aspect of this approach: systematic testing of the key molecular players regulating cell-to-cell communication in a microdomain-specific manner.
Despite strong evidence showing that Ras-family proteins contribute to various forms of synaptic plasticity, LTP, LTD, and depotentiation in particular, we know very little about how this is achieved. If the activity of these proteins is preferentially required for these forms of plasticity, reducing their activity should limit these processes. Taking advantage of their technique, Zhang et al. (2018) tested microdomain-specific Ras proteins' roles in synaptic plasticity by targeting dn-Ras proteins to various microdomains. Consistent with their observed effects on AMPAR responses, they found that targeting of dn-Ras to the ER or lipid rafts reduced and prevented LTP, respectively, and that restricted expression of dn-Rap2 in the bulk membrane and dn-Rap1 in the lysosome, respectively, prevented depotentiation and LTD. They further validated these striking microdomain-specific roles of Ras-family proteins in synaptic plasticity in a more physiological context-through viral expression of Ras proteins in specific microdomains in hippocampal CA1 neurons in intact rats-and performed electrophysiological recordings in slices acutely prepared from these rats. They found that dn-Ras in the ER or in lipid rafts repressed AMPAR currents, whereas dn-Rap2 in the bulk membrane or dn-Rap1 localized to the lysosome increased AMPAR transmission in an activity-dependent manner. These results are in good agreement with the microdomain-specific roles of Ras in the ER and lipid rafts for LTP, the bulk membrane Rap2 for depotentiation, and the lysosomal Rap1 for LTD in vivo. Collectively, these results elegantly illustrate that subcellular microdomain-specific expression of signaling molecules/complexes is a major determinant that ensures the specific role of Ras family members in mediating multiple forms of plasticity (Figure 1) .
This study significantly advances our knowledge in several ways. First, it demonstrates the power and utility of these approaches in dissecting detailed mechanisms and functions of signaling pathways in a subcellular microdomain-specific manner. Second, the study reveals that properties of signaling molecules are dictated by the subcellular microdomain in which they are housed, which, in turn, grants them privileged access to select signaling complexes. Third, these findings expand the realm of signaling parameters that influence key cellular properties to include those mediated at the subcellular compartment level. Finally, this study provides evidence that Rasfamily proteins engage microdomainselective signaling cascades to impart individual synapses with the capacity for multiple forms of plasticity. Coupling of microdomain-selective signaling to regulation of distinct AMPAR subunits further bolsters our understanding of cellular processes underlying changes in synaptic transmission and opens new avenues for investigation in terms of synaptic plasticity, cognitive function, and disease.
The present study has significance far beyond discerning diverse functions of Ras-family proteins in synaptic plasticity. The application of this microdomaintargeting technique to a broad range of brain disease models (neurofibromatosis, Costello syndrome, autism, Alzheimer's disease, and others) could lead to a radical shift in our understanding of the basis of disease as cases of mis-targeting or compartmental overload of signaling molecules are likely to be discovered. Given the strong genetic links between Ras-family proteins and cancer (Ye and Carew, 2010) , it will be interesting to probe the dysfunction of microdomainmediated regulation of these proteins in relation to carcinomas and tumorigenesis. It may also have important implications for precision medicine, since often it is the case that only certain subcellular signaling mechanisms are defective. For instance, it has recently been reported that in fragile X syndrome, only Ras-PI3K signaling, but not Ras-ERK signaling, is impaired (Hu et al., 2008) , and microdomain-specific drugs may have improved specificity and efficacy while reducing unwanted side effects. This method may also help in microdomain-targeted genetic correction for diseases (Lim et al., 2017) .
There are several important questions arising from this study for future research. Lipid rafts are highly mobile, cholesterolrich microdomains of the plasma membrane that have previously been reported to stabilize synaptic AMPARs and promote LTP (Hou et al., 2008) . Consistently, the findings of Zhang et al. (2018) suggest that Ras expression at lipid rafts promotes LTP. However, it is unclear how Ras-ERK in the lipid rafts signal to alter LTP. Given that one of the known functions of lipid rafts is to localize signaling complexes within the confined microdomain, it would be interesting to know whether the lipid rafts here also function to confine Ras and ERK into a signaling complex close to AMPARs, thereby bolstering Ras-ERK signaling efficacy. In addition, another well-characterized function of lipid rafts is to mediate endocytosis of many raftresident proteins; it would therefore also be interesting to know whether Ras-ERK in the lipid rafts promotes LTP by inhibiting AMPAR lateral movement and/or endocytosis, thereby stabilizing them at postsynaptic domains ( Figure 1B) . Also, does Ras interact with PI3K within the ER or remotely activate PI3K signaling outside of the ER, for instance, on the plasma membrane, that then facilitates AMPAR insertion and/or lateral movement to the synapse or promotes receptor recycling back to the membrane ( Figure 1B) ? Very little is known about the role of the bulk membrane in contributing to postsynaptic receptor regulation. This raises some important questions about Rap2 signaling in depotentiation: does Rap2 recruitment of JNK in the bulk membrane promote depotentiation through increasing AMPAR lateral movement out of the synapse and/or endocytosis ( Figure 1D )? Alternatively, does Rap2 initiate simultaneous AMPAR endocytosis in tandem with shifts in the structural arrangement of the bulk membrane that facilitate retention of AMPARs outside of the synapse? Finally, it is unclear how localization of Rap1 to the lysosome drives synaptic depression-is this mechanism the result of upregulated lysosomal activity, thereby increasing degradation of endocytosed AMPARs, or due to diversion of the endocytosed receptors in the recycling endosome into lysosomes, thereby reducing their recycling back to the plasma membrane ( Figure 1F )? Additionally, it remains to be determined whether memory processes relying on these different forms of plasticity similarly rely on microdomain compartmentalization of various Ras-family isoforms and, if so, what the temporal and microdomainselective profiles are. Along these lines, how does microdomain targeting mediate interactions (crosstalk) between these forms of plasticity? Finally, how is microdomain targeting regulated by neuronal activity to shape neural circuit composition and function? It will be fascinating to watch as this approach is applied to address these questions and extended to other key molecular signaling players and models of major human disease. Here's hoping for an avalanche of ''ras''-ults!
